In recent years, studies have found that mutations in the LRRK2 gene can lead to ERS through interactions with thrombospondin-1 (THBS1)/transforming growth factor beta 1 (TGF-β1), thus playing an important role in the pathogenesis of PD [66]. This evidence concerns the gene LRRK2 and amelogenesis imperfecta type 1G.